Your browser doesn't support javascript.
loading
[Status and challenges of neoadjuvant immunotherapy for hepatocellular carcinoma].
Xia, Y X; Cao, H S; Tang, W W; Wang, X H.
Afiliación
  • Xia YX; Hepatobiliary Center, the First Affiliated Hospital of Nanjing Medical University,Key Laboratory of Liver Transplantation,Chinese Academy of Medical Sciences,National Health Commission Key Laboratory of Living Donor Liver Transplantation,Nanjing Medical University,Nanjing 210000,China.
  • Cao HS; Hepatobiliary Center, the First Affiliated Hospital of Nanjing Medical University,Key Laboratory of Liver Transplantation,Chinese Academy of Medical Sciences,National Health Commission Key Laboratory of Living Donor Liver Transplantation,Nanjing Medical University,Nanjing 210000,China.
  • Tang WW; Hepatobiliary Center, the First Affiliated Hospital of Nanjing Medical University,Key Laboratory of Liver Transplantation,Chinese Academy of Medical Sciences,National Health Commission Key Laboratory of Living Donor Liver Transplantation,Nanjing Medical University,Nanjing 210000,China.
  • Wang XH; Hepatobiliary Center, the First Affiliated Hospital of Nanjing Medical University,Key Laboratory of Liver Transplantation,Chinese Academy of Medical Sciences,National Health Commission Key Laboratory of Living Donor Liver Transplantation,Nanjing Medical University,Nanjing 210000,China.
Zhonghua Wai Ke Za Zhi ; 61(1): 7-12, 2023 Jan 01.
Article en Zh | MEDLINE | ID: mdl-36603877

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: Zh Revista: Zhonghua Wai Ke Za Zhi Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: Zh Revista: Zhonghua Wai Ke Za Zhi Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China